gimli

3BBLACKBIO stock AI analysis

3BBLACKBIO Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

3B BLACKBIO DX LTD. is a small-cap stock in Healthcare. This Gimli page shows the latest available 3BBLACKBIO price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive 3BBLACKBIO stock page

Price

₹1,333.60

1W return

-3.47%

1M return

-19.02%

3M return

+6.85%

6M return

+11.20%

1Y return

n/a

Market cap

₹n/a

n/a

ROE

+18.85%

ROCE

+24.64%

RSI

42.56

Turnover

₹0.60 cr

Why it can matter in screens

Momentum: 3BBLACKBIO is below 50DMA, below 200DMA; RSI is 42.56.
Returns: 1D +1.79%, 1W -3.47%, 1M -19.02%, 3M +6.85%, 1Y n/a.
Trend levels: 52W high ₹1,740.00, 52W low ₹1,085.00, off high -23.36%.
Liquidity: latest turnover is ₹0.60 cr; volume vs 20D is +0.26%.
Valuation/profitability: PE n/a, PB n/a, ROE +18.85%, ROCE +24.64%.
Growth: 3Y sales CAGR +28.68%, 3Y profit CAGR +30.40%.

Quick Answers

What is the latest 3BBLACKBIO stock price?

The latest stored price for 3BBLACKBIO is Rs 1,333.60 as of 2026-11-03.

Is 3BBLACKBIO above its 50DMA and 200DMA?

3BBLACKBIO is below 50DMA, below 200DMA. The latest 50DMA is 1,432.62 and the latest 200DMA is n/a.

What are 3BBLACKBIO PE, ROE and ROCE?

3BBLACKBIO has PE n/a, ROE +18.85%, and ROCE +24.64% in Gimli's latest available snapshot.

How has 3BBLACKBIO performed recently?

3BBLACKBIO has returned -19.02% over 1 month, +6.85% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	33.49 cr	14.67 cr	9.53 cr	11.11
2026-03-31	45.58 cr	18.64 cr	9.80 cr	11.44
2025-12-31	55.94 cr	27.31 cr	22.44 cr	25.32
2025-09-30	39.41 cr	20.24 cr	15.04 cr	17.55
2025-06-30	26.55 cr	16.15 cr	12.64 cr	14.67
2025-03-31	22.50 cr	12.86 cr	8.40 cr	n/a

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	141.92 cr	82.33 cr	58.59 cr	69.94
2025-03-31	105.56 cr	64.88 cr	47.56 cr	55.66
2024-03-31	83.04 cr	47.43 cr	34.21 cr	37.46
2023-03-31	66.60 cr	36.84 cr	26.42 cr	30.27
2022-03-31	25.62 cr	8.86 cr	8.01 cr	nan

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	378.00 cr	38.31 cr	3.11 cr	331.64 cr
2025-03-31	295.72 cr	12.47 cr	0.31 cr	271.00 cr
2024-03-31	248.10 cr	12.92 cr	0.79 cr	225.47 cr
2023-03-31	214.06 cr	5.24 cr	2.03 cr	195.91 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	52.48 cr	26.97 cr	n/a
2025-03-31	43.36 cr	42.45 cr	n/a
2024-03-31	26.95 cr	26.44 cr	n/a
2023-03-31	20.28 cr	18.26 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	424,658.30 cr	35.053345	+15.50%	+3.72%
DIVISLAB	DIVI S LABORATORIES LTD	267,167.60 cr	91.684145	+18.37%	+47.91%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,377.11 cr	74.094685	+16.87%	+28.16%
LAURUSLABS	LAURUS LABS LIMITED	125,408.69 cr	114.827348	+21.77%	+138.16%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	124,833.39 cr	27.818646	+16.04%	+26.46%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	121,354.29 cr	57.614911	+22.62%	+7.87%
DRREDDY	DR. REDDY S LABORATORIES	113,923.95 cr	40.698752	+7.80%	+14.41%
CIPLA	CIPLA LTD	112,841.65 cr	38.950805	+8.80%	-7.58%

Try these prompts

Analyze 3B BLACKBIO DX. with valuation, momentum and industry peers
Compare 3BBLACKBIO with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-11-03. Not investment advice.